SUPPORT US
CLINICAL TRIALS
FOLLOW OUR RESEARCH
RESEARCH NEWS
2019 Highlights
Projects
Clinical Trials
samples received
Allied Health
Researchers
Even modest therapeutic advances that delay disease onset and
progression could significantly reduce the burden of the disease
on patients and the level of care required.
to gluten. For people with coeliac disease, even small amounts of gluten can damage the
lining of the small intestine (bowel). We’re undertaking research initiatives that will help
discover new ways to diagnose, treat, and manage Coeliac Disease.
in childhood. Individuals with TS make involuntary movements
and vocalisations (known as tics), which may be painful,
embarassing, and functionally impairing.
that enable us to move, speak, breath, and swallow slowly fail to work normally.
Research is sorely needed to understand and alter the progression of this condition.
A new lease on life for Kym
In 2017 Kym’s life was full and happy. But what Kym didn’t know was that a rare genetic disease, Porphyria, was now waking within her body. A clinical trial for a new therapy is providing hope that life could return to normal.
2020 Justin Cameron Cancer Care Foundation Anniversary
On January 10, Wesley Medical Research hosts an annual celebration with family and friends of the Justin Cameron Cancer Care Foundation.
A new lease on life for Kym
In 2017 Kym’s life was full and happy. But what Kym didn’t know was that a rare genetic disease, Porphyria, was now waking within her body. A clinical trial for a new therapy is providing hope that life could return to normal.
2020 Justin Cameron Cancer Care Foundation Anniversary
On January 10, Wesley Medical Research hosts an annual celebration with family and friends of the Justin Cameron Cancer Care Foundation.
Regional QLD Changing Waistlines and Mindsets with New Toolkit
Research tackling the growing obesity problem in Emerald, Central Queensland.
Painful Stones Could be a Distant Memory
A new clinical trial is set to explore the efficacy of a new form of treatment using a device called the Enhanced Lithotripsy System (ELS) for urinary stones.
Predicting Responses to Treatment for Cardiac Amyloidosis
Cardiologist Dr Ben Fitzgerald is seeking to identify differences in cardiac characteristics between patients who respond to treatment and those who do not in the hope of determining which patients will be more likely to respond to therapy
A Novel Prostate Cancer Trial is Delivering More Options for Patients
Prostate cancer is the third most common cause of death in Australia, with 20,000 diagnoses and close to 3,300 deaths each year. A novel prostate cancer trial is delivering more options for patients.
Key Partners
Our key partners help us deliver the very best in research and help with the fight against deadly disease.
